These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27838214)

  • 1. Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review.
    Sheehan R; Hassiotis A
    Lancet Psychiatry; 2017 Mar; 4(3):238-256. PubMed ID: 27838214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability.
    de Kuijper G; Evenhuis H; Minderaa RB; Hoekstra PJ
    J Intellect Disabil Res; 2014 Jan; 58(1):71-83. PubMed ID: 23046144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
    Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
    J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
    de Kuijper GM; Hoekstra PJ
    J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Open-Label Discontinuation Trial of Long-Term, Off-Label Antipsychotic Medication in People With Intellectual Disability: Determinants of Success and Failure.
    de Kuijper GM; Hoekstra PJ
    J Clin Pharmacol; 2018 Nov; 58(11):1418-1426. PubMed ID: 29920689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of barbiturate antiepileptic drug discontinuation on antipsychotic medication dose in individuals with intellectual disability.
    Hanzel TE; Bauernfeind JD; Kalachnik JE; Harder SR
    J Intellect Disabil Res; 2000 Apr; 44 ( Pt 2)():155-63. PubMed ID: 10898379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Off-label prescription of antipsychotics].
    Boot E
    Ned Tijdschr Geneeskd; 2017; 161():D2035. PubMed ID: 29171377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of controlled discontinuation of long-term used antipsychotics on weight and metabolic parameters in individuals with intellectual disability.
    de Kuijper G; Mulder H; Evenhuis H; Visser F; Hoekstra PJ
    J Clin Psychopharmacol; 2013 Aug; 33(4):520-4. PubMed ID: 23775048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open label discontinuation trial of long-term used off-label antipsychotic drugs in people with intellectual disability: The influence of staff-related factors.
    de Kuijper GM; Hoekstra PJ
    J Appl Res Intellect Disabil; 2019 Mar; 32(2):313-322. PubMed ID: 30264420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of antipsychotics in people with intellectual disability.
    Frighi V; Stephenson MT; Morovat A; Jolley IE; Trivella M; Dudley CA; Anand E; White SJ; Hammond CV; Hockney RA; Barrow B; Shakir R; Goodwin GM
    Br J Psychiatry; 2011 Oct; 199(4):289-95. PubMed ID: 21816867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience.
    Shankar R; Wilcock M; Deb S; Goodey R; Corson E; Pretorius C; Praed G; Pell A; Vujkovic D; Wilkinson E; Laugharne R; Axby S; Sheehan R; Alexander R
    J Appl Res Intellect Disabil; 2019 Nov; 32(6):1389-1400. PubMed ID: 31192534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Support staff's perceptions of discontinuing antipsychotics in people with intellectual disabilities in residential care: A mixed-method study.
    Kleijwegt B; Pruijssers A; de Jong-Bakker L; de Haan K; van Os-Medendorp H; van Meijel B
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):861-870. PubMed ID: 30790388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
    Ruedrich SL; Swales TP; Rossvanes C; Diana L; Arkadiev V; Lim K
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):132-40. PubMed ID: 18197952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic and diagnostic profiles of older people with intellectual disability and prescription of antipsychotics.
    Axmon A; Ahlström G; Gagnemo Persson R; Eberhard J
    Soc Psychiatry Psychiatr Epidemiol; 2019 Aug; 54(8):937-944. PubMed ID: 30903237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics withdrawal in adults with intellectual disability and challenging behaviour: study protocol for a multicentre double-blind placebo-controlled randomised trial.
    Beumer S; Hamers P; Oppewal A; Maes-Festen D
    BMC Psychiatry; 2021 Sep; 21(1):439. PubMed ID: 34488701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in people with intellectual disability who use long-term antipsychotic drugs for challenging behaviour.
    Ramerman L; Hoekstra PJ; de Kuijper G
    Res Dev Disabil; 2018 Apr; 75():49-58. PubMed ID: 29482036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.